Gossamer Bio announced it raised $120 Million in an initial filing from an offering of $120 Million
Jul 18, 2022•about 3 years ago
Amount Raised
$120 Million
San DiegoBiopharmaTherapeuticsPharmaceuticalBiotechnology
Company Information
Company
Gossamer Bio
Location
3013 SCIENCE PARK
San Diego, California, United States
About
Gossamer Bio is a San Diego-based clinical-stage biopharmaceutical company focused on the development and commercialization of seralutinib for the treatment of pulmonary arterial hypertension. Our goal is to enhance the lives of people living with pulmonary hypertension.
San Diego